Desai Anushka V, Rani Rohan, Minhas Anum S, Rahman Faisal
Georgetown University School of Medicine, Washington, DC 20007, USA.
Division of Cardiology, Johns Hopkins University School of Medicine, 600 N Wolfe St, Halsted 500, Baltimore, MD 21287, USA.
J Clin Med. 2024 Dec 31;14(1):180. doi: 10.3390/jcm14010180.
Cardiogenic shock (CS) is associated with high mortality, particularly in women. With early intervention being a cornerstone of CS management, this study aims to explore whether sex differences exist in the utilization of critical interventions, timing of treatment, and in-hospital mortality for patients with acute myocardial infarction (AMI) and non-AMI-CS. For this retrospective cohort study, we queried the National Inpatient Sample (years 2016-2021) for CS-related hospitalizations. We assessed sex differences in utilization, timing, and outcomes of CS interventions, adjusting for demographics, comorbidities, and prior cardiac interventions via multivariate logistic regressions. Of 1,052,360 weighted CS hospitalizations, 60% were for non-AMI-CS and 40% were for AMI-CS. Women with CS had lower rates of all interventions. For AMI-CS, women had higher likelihoods of in-hospital mortality after revascularization (adjusted odds ratio 1.15 [95% confidence interval 1.09-1.22]), mechanical circulatory support (MCS) (1.15 [1.08-1.22]), and right heart catheterization (RHC) (1.10 [1.02-1.19]) (all < 0.001). Similar trends were seen in the non-AMI-CS group. Women with AMI-CS were less likely to receive early (within 24 h of admission) revascularization (0.93 [0.89-0.96]), MCS (0.76 [0.73-0.80]), or RHC (0.89 [0.84-0.95]); women with non-AMI-CS were less likely to receive early revascularization (0.78 [0.73-0.84]) or RHC (0.83 [0.79-0.88]) (all < 0.001). Regardless of CS type, in-hospital mortality was not significantly different between men and women receiving early MCS or revascularization. Sex disparities in the frequency of treatment of CS persist on a national scale, with women being more likely to die following treatment and less likely to receive early treatment. However, in-hospital mortality does not differ significantly when men and women are treated equally within 24 h of admission, suggesting that early intervention should be made a priority to mitigate sex-based differences in CS outcomes.
心源性休克(CS)与高死亡率相关,尤其是在女性中。早期干预是CS管理的基石,本研究旨在探讨急性心肌梗死(AMI)和非AMI-CS患者在关键干预措施的使用、治疗时机和院内死亡率方面是否存在性别差异。在这项回顾性队列研究中,我们查询了国家住院样本(2016 - 2021年)中与CS相关的住院病例。我们评估了CS干预措施在使用、时机和结果方面的性别差异,并通过多因素逻辑回归对人口统计学、合并症和既往心脏干预进行了调整。在1,052,360例加权的CS住院病例中,60%为非AMI-CS,40%为AMI-CS。患有CS的女性接受所有干预措施的比例较低。对于AMI-CS,女性在血运重建后院内死亡的可能性更高(调整后的优势比为1.15 [95%置信区间1.09 - 1.22]),机械循环支持(MCS)(1.15 [1.08 - 1.22])和右心导管插入术(RHC)(1.10 [1.02 - 1.19])(均P < 0.001)。在非AMI-CS组中也观察到了类似趋势。患有AMI-CS的女性接受早期(入院后24小时内)血运重建的可能性较小(0.93 [0.89 - 0.96])、MCS(0.76 [0.73 - 0.80])或RHC(0.89 [0.84 - 0.95]);患有非AMI-CS的女性接受早期血运重建(0.78 [0.73 - 0.84])或RHC(0.83 [0.79 - 0.88])的可能性较小(均P < 0.001)。无论CS类型如何,接受早期MCS或血运重建的男性和女性的院内死亡率没有显著差异。CS治疗频率方面的性别差异在全国范围内持续存在,女性在治疗后死亡的可能性更大,接受早期治疗的可能性更小。然而,当男性和女性在入院后24小时内接受同等治疗时,院内死亡率没有显著差异,这表明应优先进行早期干预,以减轻CS结局中的性别差异。